Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Once-weekly oral aripiprazole for children and adolescents with Tourette's disorder
2011-000468-83Phase 3Terminated
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Tourette syndrome (TS) comparing Aripiprazole once-weekly with Placebo (2 arms). Primary endpoint: Change from baseline to endpoint in YGTSS Total Tic Score. Started Jun 2011; status: terminated.
02
Drugs
aripiprazole
03
Conditions
Tourette syndrome (TS)
Beyond the preview
Go deeper on 2011-000468-83.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-000468-83.